Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma
Glioblastoma (GBM) is one of the most prevalent and aggressive cancers worldwide. The overall survival period of GBM patients is only 15 months even with standard combination therapy. The absence of validated biomarkers for early diagnosis mainly accounts for worse clinical outcomes of GBM patients....
Main Authors: | Kun Liu, Hong Chen, Yuanyuan Wang, Liping Jiang, Yi Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.846864/full |
Similar Items
-
Long, Noncoding RNA Dysregulation in Glioblastoma
by: Patrick A. DeSouza, et al.
Published: (2021-03-01) -
In silico characterization of competing endogenous RNA network in glioblastoma multiforme with a systems biology approach
by: Soudeh Ghafouri-Fard, et al.
Published: (2022-10-01) -
Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer
by: Shasha Xiang, et al.
Published: (2024-03-01) -
Current insights into the molecular systems pharmacology of lncRNA-miRNA regulatory interactions and implications in cancer translational medicine
by: Sujit Nair
Published: (2016-04-01) -
Co-expression analysis and ceRNA network reveal eight novel potential lncRNA biomarkers in hepatocellular carcinoma
by: Ren-chao Zou, et al.
Published: (2019-12-01)